| Name | milademetan |
|---|---|
| Synonyms |
R3I80TLN7S
DS-3032 milademetan |
| Description | Mliademetan is a specific MDM2 inhibitor, a pharmaceutical composition for use in treating acute myeloid leukemia (AML). |
|---|---|
| Related Catalog | |
| Target |
MDM2[1]. |
| References |
| Density | 1.4±0.1 g/cm3 |
|---|---|
| Boiling Point | 840.7±65.0 °C at 760 mmHg |
| Molecular Formula | C30H34Cl2FN5O4 |
| Molecular Weight | 618.526 |
| Flash Point | 462.2±34.3 °C |
| Exact Mass | 617.197205 |
| LogP | 3.54 |
| Vapour Pressure | 0.0±3.1 mmHg at 25°C |
| Index of Refraction | 1.646 |
| Storage condition | 2-8℃ |